Iridex (NASDAQ: IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $12.566 million which missed the analyst consensus estimate of $13.587 million by 7.51 percent. This is a 7.41 percent decrease over sales of $13.571 million the same period last year.